CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer

BACKGROUND: Considering neoadjuvant chemotherapy (NAC) prior to surgery could shrink and reduce the primary tumor and distant micro-metastases to reduce the high relapses rates, NAC has been an accepted therapeutic management for patients with non-small cell lung cancer (NSCLC). CMTM1_v17 is highly...

Descripción completa

Detalles Bibliográficos
Autores principales: Si, Jiahui, Zhang, Panpan, Tian, Dan, Wang, Xing, Ma, Yuanyuan, Zhang, Jianzhi, Wang, Lu, Yang, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5273821/
https://www.ncbi.nlm.nih.gov/pubmed/28129775
http://dx.doi.org/10.1186/s12957-016-1094-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5273821/
https://www.ncbi.nlm.nih.gov/pubmed/28129775
http://dx.doi.org/10.1186/s12957-016-1094-z

Ejemplares similares